B Cells, Antibodies, and More.

B cells play a central role in the immunopathogenesis of glomerulonephritides and transplant rejection. B cells secrete antibodies that contribute to tissue injury via multiple mechanisms. In addition, B cells contribute to disease pathogenesis in autoimmunity and alloimmunity by presenting antigens as well as providing costimulation and cytokines to T cells. B cells also play an immunomodulatory role in regulating the immune response by secreting cytokines that inhibit disease onset and/or progression. B cell-targeted approaches for treating immune diseases of the kidney and other organs have gained significant momentum. However, much remains to be understood about B-cell biology in order to determine the timing, duration, and context of optimal therapeutic response to B cell-targeted approaches. In this review, we discuss the multifaceted roles of B cells as enhancers and regulators of immunity with relevance to kidney disease and transplantation.

[1]  D. Liggitt,et al.  Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells , 2013, Nature Immunology.

[2]  M. Shlomchik,et al.  B Cell–Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus , 2015, The Journal of Immunology.

[3]  D. Jayne,et al.  B-cell depletion in the treatment of lupus nephritis , 2012, Nature Reviews Nephrology.

[4]  J. Kearney,et al.  Marginal Zone, but Not Follicular B Cells, Are Potent Activators of Naive CD4 T Cells1 , 2004, The Journal of Immunology.

[5]  F. Nimmerjahn,et al.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system? , 2013, Nature Reviews Immunology.

[6]  Amit Bar-Or,et al.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases , 2014, Nature.

[7]  F. Delbos,et al.  Multiple layers of B cell memory with different effector functions , 2009, Nature Immunology.

[8]  P. Lipsky,et al.  Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1 , 2000, The Journal of Immunology.

[9]  E. L. Prak,et al.  Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus , 2008, Annals of the rheumatic diseases.

[10]  G. Tsokos,et al.  B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. , 1996, The Journal of clinical investigation.

[11]  R. Maciuca,et al.  Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study. , 2013, Arthritis and rheumatism.

[12]  Kenneth G. C. Smith,et al.  B-cell-depleting induction therapy and acute cellular rejection. , 2009, The New England journal of medicine.

[13]  F. Alt,et al.  Class-switch recombination: interplay of transcription, DNA deamination and DNA repair , 2004, Nature Reviews Immunology.

[14]  K. Lai Pathogenesis of IgA nephropathy , 2012, Nature Reviews Nephrology.

[15]  C. Loddenkemper,et al.  Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. , 2010, Immunity.

[16]  D. Isenberg,et al.  Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus. , 2013, Arthritis and rheumatism.

[17]  J. Cyster,et al.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.

[18]  V. Hadjianastassiou,et al.  Rituximab in renal transplantation , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[19]  M. Krumbholz,et al.  BAFF is elevated in serum of patients with Wegener's granulomatosis. , 2005, Journal of autoimmunity.

[20]  J. Fechner,et al.  BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  D. Sansonno,et al.  Activation‐induced cytidine deaminase in B cells of hepatits C virus‐related cryoglobulinaemic vasculitis , 2015, Clinical and experimental immunology.

[22]  B. Ryffel,et al.  IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. , 1997, Journal of immunology.

[23]  I. Sanz,et al.  Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. , 2007, Arthritis and rheumatism.

[24]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[25]  E. Thervet,et al.  Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study , 2010, Transplantation.

[26]  S. Nutt,et al.  Germinal center B and follicular helper T cells: siblings, cousins or just good friends? , 2011, Nature Immunology.

[27]  U. Panzer,et al.  Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. , 2008, Kidney international.

[28]  P. van Paassen,et al.  Regulatory B cells in ANCA-associated vasculitis , 2013, Annals of the rheumatic diseases.

[29]  G. Remuzzi,et al.  Rituximab in idiopathic membranous nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[30]  E. Ginzler,et al.  Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE , 2013, Lupus.

[31]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[32]  L. Turka,et al.  B cells with immune-regulating function in transplantation , 2014, Nature Reviews Nephrology.

[33]  M. Petri,et al.  Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response , 2012, Annals of the rheumatic diseases.

[34]  C. Croce,et al.  The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells , 2015, Leukemia.

[35]  H. Zola,et al.  Blood group antibodies are made by CD5+ and by CD5− B cells , 1997, Immunology and cell biology.

[36]  A. Loupy,et al.  The impact of donor-specific anti-HLA antibodies on late kidney allograft failure , 2012, Nature Reviews Nephrology.

[37]  R. Colvin,et al.  Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  C. Cohen,et al.  The contribution of B cells to renal interstitial inflammation. , 2007, The American journal of pathology.

[39]  M. Rastaldi,et al.  CD20-positive infiltrates in human membranous glomerulonephritis. , 2005, Journal of nephrology.

[40]  D. Laplaud,et al.  Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties. , 2015, Journal of the American Society of Nephrology : JASN.

[41]  K. Fairfax,et al.  The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity , 2013, Cytokine & Growth Factor Reviews.

[42]  B. Diamond,et al.  Selective dysregulation of the FcγIIB receptor on memory B cells in SLE , 2006, The Journal of Experimental Medicine.

[43]  X. Jouven,et al.  Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.

[44]  Keiichiro Suzuki,et al.  Roles of B‐1 and B‐2 cells in innate and acquired IgA‐mediated immunity , 2010, Immunological reviews.

[45]  David Allman,et al.  Regulation of peripheral B cell maturation. , 2006, Cellular immunology.

[46]  K. Tarte,et al.  Unique B Cell Differentiation Profile in Tolerant Kidney Transplant Patients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  H. Rabb,et al.  B cells limit repair after ischemic acute kidney injury. , 2010, Journal of the American Society of Nephrology : JASN.

[48]  Irene Puga,et al.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes , 2013, Nature Reviews Immunology.

[49]  T. Singh,et al.  B cells mediate chronic allograft rejection independently of antibody production. , 2014, The Journal of clinical investigation.

[50]  J. Michel,et al.  Immune Responses Elicited in Tertiary Lymphoid Tissues Display Distinctive Features , 2010, PloS one.

[51]  F. Carrat,et al.  Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. , 2012, Blood.

[52]  A. Challa,et al.  ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process , 2011, Annals of the rheumatic diseases.

[53]  E. Ritz,et al.  In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis , 1993 .

[54]  S. Gauld,et al.  B-cell anergy: from transgenic models to naturally occurring anergic B cells? , 2007, Nature Reviews Immunology.

[55]  A. Rajeswaran,et al.  Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial , 2012, Arthritis Research & Therapy.

[56]  N. Baumgarth The double life of a B-1 cell: self-reactivity selects for protective effector functions , 2011, Nature Reviews Immunology.

[57]  P. Milpied,et al.  Switched-memory B cells remodel B cell receptors within secondary germinal centers , 2015, Nature Immunology.

[58]  R. Colvin,et al.  Chronic Humoral Rejection of Human Kidney Allografts Associates With Broad Autoantibody Responses , 2010, Transplantation.

[59]  G. Cattoretti,et al.  Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo1 , 2000, The Journal of Immunology.

[60]  M. Sayegh,et al.  Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. , 2011, The Journal of clinical investigation.

[61]  S. Tangye,et al.  BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. , 2003, The Journal of clinical investigation.

[62]  Hailong Meng,et al.  CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype , 2014, Nature Immunology.

[63]  C. Cunningham-Rundles,et al.  CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance , 2007, The Journal of experimental medicine.

[64]  A. Gabrielli,et al.  A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. , 2012, Arthritis and rheumatism.

[65]  A. Cappione,et al.  Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[66]  G. Silverman,et al.  Protective Roles of Natural IgM Antibodies , 2012, Front. Immun..

[67]  G. Tsokos,et al.  T cells as a therapeutic target in SLE , 2015, Lupus.

[68]  R. Colvin,et al.  Chronic alloantibody mediated rejection. , 2012, Seminars in immunology.

[69]  B. Volpe,et al.  XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development , 2009, The Journal of experimental medicine.

[70]  G. Vidarsson,et al.  A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. , 2014, Blood.

[71]  D. Chaplin,et al.  B Lymphocytes Induce the Formation of Follicular Dendritic Cell Clusters in a Lymphotoxin α–dependent Fashion , 1998, The Journal of experimental medicine.

[72]  R. Pelanda,et al.  This information is current as Signaling Transitional B Cells following Tonic BCR Differentiation of Immature B Cells into BAFF Receptor Signaling Aids the , 2010 .

[73]  M. Shlomchik,et al.  Germinal center selection and the development of memory B and plasma cells , 2012, Immunological reviews.

[74]  K. P. Murphy,et al.  Janeway's immunobiology , 2007 .

[75]  D. Gladman,et al.  Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials , 2012, Annals of the rheumatic diseases.

[76]  M. Moser,et al.  B Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo , 2000, The Journal of experimental medicine.

[77]  R. Maciuca,et al.  Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. , 2012, Arthritis and rheumatism.

[78]  David M. Beck,et al.  Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[79]  M. Suthanthiran,et al.  Identification of a B cell signature associated with renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.

[80]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.

[81]  G. Springer,et al.  Blood group isoantibody stimulation in man by feeding blood group-active bacteria. , 1969, The Journal of clinical investigation.

[82]  M. Giger,et al.  Cell Distance Mapping Identifies Functional T Follicular Helper Cells in Inflamed Human Renal Tissue , 2014, Science Translational Medicine.

[83]  T. Randall,et al.  B Cells Are Required for Generation of Protective Effector and Memory CD4 Cells in Response to Pneumocystis Lung Infection , 2006, The Journal of Immunology.

[84]  D. Wishart,et al.  Transplant Glomerulopathy, Late Antibody‐Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopsies for Cause , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[85]  R. Redfield,et al.  Murine Islet Allograft Tolerance Upon Blockade of the B-Lymphocyte Stimulator, BLyS/BAFF , 2012, Transplantation.

[86]  R. V. van Lier,et al.  B Cells Are Crucial for Both Development and Maintenance of the Splenic Marginal Zone1 , 2004, The Journal of Immunology.

[87]  Kim L Kusser,et al.  Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. , 2009, Immunity.

[88]  D. Rothstein,et al.  Non-Antibody Mediated Roles of B Cells in Allograft Survival , 2014, Current Transplantation Reports.

[89]  J. Thurman,et al.  B Cell Subsets Contribute to Renal Injury and Renal Protection after Ischemia/Reperfusion , 2010, The Journal of Immunology.

[90]  L. Sandu CORTICOSTEROIDS IN LANDRY-GUILLAIN-BARRÉ-STROHL SYNDROME , 1974 .

[91]  A. Salama,et al.  Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis. , 2014, Rheumatology.

[92]  M. Shlomchik,et al.  Cutting Edge: B Cells Promote CD8+ T Cell Activation in MRL-Faslpr Mice Independently of MHC Class I Antigen Presentation1 , 2000, The Journal of Immunology.

[93]  M. Shlomchik,et al.  A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.

[94]  A. Cherukuri,et al.  Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells. , 2014, Journal of the American Society of Nephrology : JASN.

[95]  A. Naji,et al.  B Cell-Mediated Antigen Presentation Is Required for the Pathogenesis of Acute Cardiac Allograft Rejection1 , 2006, The Journal of Immunology.

[96]  G. Wallukat,et al.  Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. , 2005, The New England journal of medicine.

[97]  R. Flavell,et al.  Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen Receptor , 1996, Cell.

[98]  J. Michel,et al.  Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[99]  M. Busslinger,et al.  Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.

[100]  J. Lozano,et al.  Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[101]  D. Isenberg,et al.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. , 2010, Immunity.

[102]  T. Randall,et al.  Effector and regulatory B cells: modulators of CD4+ T cell immunity , 2010, Nature Reviews Immunology.

[103]  M. Ehrenstein,et al.  The 'short' history of regulatory B cells. , 2008, Trends in immunology.

[104]  W. Suki,et al.  Bortezomib in kidney transplant desensitization: a case report. , 2009, Clinical transplants.

[105]  A. El-Husseini,et al.  Refractory Henoch-Schönlein purpura: atypical aetiology and management. , 2013, Journal of renal care.

[106]  Graham M Lord,et al.  Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.

[107]  A. DeFranco,et al.  B Cell–Specific Loss of Lyn Kinase Leads to Autoimmunity , 2014, The Journal of Immunology.

[108]  V. Pascual,et al.  Defective B cell tolerance checkpoints in systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[109]  J. Ravetch,et al.  Identification of a receptor required for the anti-inflammatory activity of IVIG , 2008, Proceedings of the National Academy of Sciences.

[110]  Thomas Boehm,et al.  Human Immunoglobulin M Memory B Cells Controlling Streptococcus pneumoniae Infections Are Generated in the Spleen , 2003, The Journal of experimental medicine.

[111]  E. Montecino-Rodriguez,et al.  B-1 B cell development in the fetus and adult. , 2012, Immunity.

[112]  D. Schatz,et al.  Somatic Hypermutation of Immunoglobulin Genes Merging Mechanisms for Genetic Diversity , 2002, Cell.

[113]  R. Bram,et al.  BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.

[114]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[115]  D. Gray,et al.  TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells , 2007, European journal of immunology.

[116]  W. Baldwin,et al.  B Cell Deficiency Confers Protection from Renal Ischemia Reperfusion Injury 1 , 2003, The Journal of Immunology.

[117]  G. Vidarsson,et al.  IgG-effector functions: "the good, the bad and the ugly". , 2014, Immunology letters.

[118]  Z. Dai,et al.  Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. , 1999, Transplantation.

[119]  M. Sarwal,et al.  Characterization of intra-graft B cells during renal allograft rejection. , 2008, Kidney international.

[120]  U. Klein,et al.  The diverse roles of IRF4 in late germinal center B‐cell differentiation , 2012, Immunological reviews.

[121]  T. Rothstein,et al.  Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of experimental medicine.

[122]  B. Rovin,et al.  A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). , 2015, Nephron.

[123]  G. Ewald,et al.  Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation. , 2010, Human immunology.

[124]  A. Gaber,et al.  Bortezomib in Kidney Transplantation , 2010, Journal of transplantation.

[125]  M. Scott,et al.  Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant Cells , 2003, The Journal of experimental medicine.

[126]  P. Merkel,et al.  Efficacy of remission-induction regimens for ANCA-associated vasculitis. , 2013, The New England journal of medicine.

[127]  Wu Xin-xing,et al.  CD19+CD5+ B cells in primary IgA nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[128]  K. Calame,et al.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow , 2005, The Journal of experimental medicine.

[129]  C. Cohen,et al.  Intrarenal production of B-cell survival factors in human lupus nephritis , 2011, Modern Pathology.

[130]  R. Horton,et al.  Visualization of splenic marginal zone B cell shuttling and follicular B cell egress , 2012, Nature.

[131]  P. Lipsky,et al.  Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. , 2008, Arthritis and rheumatism.

[132]  U. Klein,et al.  Article Transcriptional Regulation of Germinal Center B and Plasma Cell Fates by Dynamical Control of Irf4 , 2022 .

[133]  J. Platt,et al.  Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation , 2004, Nature Medicine.

[134]  D. Gray,et al.  TLR and B Cell Receptor Signals to B Cells Differentially Program Primary and Memory Th1 Responses to Salmonella enterica , 2010, The Journal of Immunology.

[135]  C. Tato,et al.  Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.

[136]  P. Emery,et al.  B cell biomarkers of rituximab responses in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[137]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[138]  R. Colvin,et al.  Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. , 2001, Journal of the American Society of Nephrology : JASN.

[139]  J. Coles,et al.  ABO-incompatible heart transplantation in infants. , 2001, The New England journal of medicine.

[140]  S. Tangye To B1 or not to B1: that really is still the question! , 2013, Blood.

[141]  Kenneth G. C. Smith,et al.  FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications , 2010, Nature Reviews Immunology.

[142]  K. Latinis,et al.  Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial , 2012, The Journal of Rheumatology.

[143]  J. Cyster,et al.  S1PR2 links germinal center confinement and growth regulation , 2012, Immunological reviews.

[144]  T. Tedder,et al.  Regulatory B cells as inhibitors of immune responses and inflammation , 2008, Immunological reviews.

[145]  R. Ahmed,et al.  A Specific Role for B Cells in the Generation of CD8 T Cell Memory by Recombinant Listeria monocytogenes 1 , 2003, The Journal of Immunology.

[146]  J. Kearney,et al.  Marginal-zone B cells , 2002, Nature Reviews Immunology.

[147]  H. Schild,et al.  Donor and host B cell‐derived IL‐10 contributes to suppression of graft‐versus‐host disease , 2014, European journal of immunology.

[148]  Hedda Wardemann,et al.  B-cell tolerance checkpoints in health and autoimmunity. , 2008, Current opinion in immunology.

[149]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[150]  O. Fjeldborg,et al.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. , 1966, Lancet.

[151]  Yichun Hu,et al.  Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[152]  M. Sarwal,et al.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. , 2003, The New England journal of medicine.

[153]  P. Heeringa,et al.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.

[154]  S. Liossis,et al.  Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments , 2014, Expert Opinion on Pharmacotherapy.

[155]  J. Ritz,et al.  B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. , 2012, Blood.

[156]  R. Sachidanandam,et al.  Antibodies reactive to non-HLA antigens in transplant glomerulopathy. , 2011, Journal of the American Society of Nephrology : JASN.

[157]  G. Yaari,et al.  Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. , 2011, Immunity.

[158]  I. Pastan,et al.  CD21−/low Marginal Zone B Cells Highly Express Fc Receptor–like 5 Protein and Are Killed by Anti–Fc Receptor–like 5 Immunotoxins in Hepatitis C Virus–Associated Mixed Cryoglobulinemia Vasculitis , 2014, Arthritis & rheumatology.

[159]  T. Rothstein,et al.  A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus , 2011, The Journal of experimental medicine.

[160]  R. Cron,et al.  Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. , 2009, The Journal of pediatrics.

[161]  A. Cappione,et al.  Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. , 2005, The Journal of clinical investigation.

[162]  D. Gray,et al.  Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells1 , 2006, The Journal of Immunology.

[163]  C. Kallenberg,et al.  Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. , 2014, Rheumatology.

[164]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[165]  F. Mackay,et al.  Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus , 2013, Lupus.

[166]  Huaxi Xu,et al.  Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10–Producing Regulatory B Cells , 2010, The Journal of Immunology.

[167]  S. Brouard,et al.  BAFF and BAFF‐R Levels Are Associated With Risk of Long‐Term Kidney Graft Dysfunction and Development of Donor‐Specific Antibodies , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[168]  C. Pusey,et al.  B-cell-targeted therapy in adult glomerulonephritis , 2013, Expert opinion on biological therapy.

[169]  S. Segerer,et al.  B cells and tertiary lymphoid organs in renal inflammation. , 2008, Kidney international.

[170]  Irene Puga,et al.  Activation of B cells by non‐canonical helper signals , 2012, EMBO reports.

[171]  T. Coffman,et al.  B Lymphocytes Differentially Influence Acute and Chronic Allograft Rejection in Mice , 2011, The Journal of Immunology.

[172]  J. Pers,et al.  Maturation and function of human dendritic cells are regulated by B lymphocytes. , 2012, Blood.

[173]  T. Kurosaki,et al.  Memory B cells , 2015, Nature Reviews Immunology.

[174]  M. Fujimoto,et al.  Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. , 2008, The Journal of clinical investigation.

[175]  S. Tangye,et al.  IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-41 , 2008, The Journal of Immunology.

[176]  R. Fairchild,et al.  Role of TNFα in Early Chemokine Production and Leukocyte Infiltration into Heart Allografts , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[177]  R. Maul,et al.  Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response , 2011, Science.

[178]  Liping Huang,et al.  Natural IgM Anti-Leukocyte Autoantibodies Attenuate Excess Inflammation Mediated by Innate and Adaptive Immune Mechanisms Involving Th-17 , 2012, The Journal of Immunology.

[179]  C. Pusey,et al.  Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[180]  G. Chalasani,et al.  B Cells Help Alloreactive T Cells Differentiate Into Memory T Cells , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[181]  J. Cyster,et al.  Splenic T Zone Development Is B Cell Dependent , 2001, The Journal of experimental medicine.

[182]  Kenneth G. C. Smith,et al.  Local renal autoantibody production in lupus nephritis. , 2011, Journal of the American Society of Nephrology : JASN.

[183]  E. Morelon,et al.  Intragraft Th17 Infiltrate Promotes Lymphoid Neogenesis and Hastens Clinical Chronic Rejection , 2010, The Journal of Immunology.

[184]  Masaki Kobayashi,et al.  Serum Levels of BAFF and APRIL in Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis: Association with Disease Activity , 2011, Nephron Clinical Practice.

[185]  A. Finnegan,et al.  Expression of CD80/86 on B Cells Is Essential for Autoreactive T Cell Activation and the Development of Arthritis1 , 2007, The Journal of Immunology.

[186]  J. Cyster,et al.  Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5 , 2004, Nature Immunology.

[187]  Philip D. Hodgkin,et al.  The generation of antibody-secreting plasma cells , 2015, Nature Reviews Immunology.

[188]  E. Meffre,et al.  In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis , 2011, The Journal of Immunology.

[189]  C. Bailey-Kellogg,et al.  Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. , 2013, The Journal of clinical investigation.

[190]  E. S. St. Clair,et al.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.

[191]  K. Brorson,et al.  Post-translational structural modifications of immunoglobulin G and their effect on biological activity , 2014, Analytical and Bioanalytical Chemistry.

[192]  M. Rybojad,et al.  Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.